Ascend Wellness Holdings (AAWH) Non Operating Income (2020 - 2026)
Ascend Wellness Holdings (AAWH) recorded quarterly Non Operating Income of -$20.1 million in Q1 2026, down 10751.85% quarter-over-quarter from $189000.0 in Q4 2025, and down 4320.55% on a YoY basis from $477000.0 in Q1 2025.
Ascend Wellness Holdings (AAWH) Non Operating Income (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Non Operating Income history runs 7 years deep, the most recent figure standing at -$20.1 million for Q1 2026.
- In Q1 2026, Non Operating Income fell 4320.55% year-over-year to -$20.1 million; the TTM figure through Mar 2026 stood at -$31.2 million (down 190.55% YoY), while the FY2025 annual figure was $1.5 million, up 110.89% from the prior year.
- Non Operating Income was -$20.1 million for Q1 2026 at Ascend Wellness Holdings, down from $189000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $33.2 million in Q4 2024 to a low of -$32.2 million in Q4 2022.
- Historically, Non Operating Income has averaged -$133823.5 across 5 years, with a median of $310000.0 in 2024.
- The sharpest annual moves came in 2022 and 2023: Non Operating Income slumped 64514.0% in 2022, then soared 15823.18% in 2023.
- A 5-year view of Non Operating Income shows it stood at -$32.2 million in 2022, then surged by 101.96% to $632000.0 in 2023, then soared by 5147.31% to $33.2 million in 2024, then slumped by 99.43% to $189000.0 in 2025, then plunged by 10751.85% to -$20.1 million in 2026.
- The last three Non Operating Income figures came in at -$20.1 million (Q1 2026), $189000.0 (Q4 2025), and $341000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Ascend Wellness Holdings | - | - | 44.88 Mn | -20.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.13 Mn |
| Dec 31, 2025 | 189,000.00 |
| Sep 30, 2025 | 341,000.00 |
| Jun 30, 2025 | -11.57 Mn |
| Mar 31, 2025 | 477,000.00 |
| Dec 31, 2024 | 33.16 Mn |
| Sep 30, 2024 | 409,000.00 |
| Jun 30, 2024 | 379,000.00 |
| Mar 31, 2024 | 310,000.00 |
| Dec 31, 2023 | 632,000.00 |
| Sep 30, 2023 | 902,000.00 |
| Jun 30, 2023 | 24.04 Mn |
| Mar 31, 2023 | 265,000.00 |
| Dec 31, 2022 | -32.21 Mn |
| Sep 30, 2022 | 273,000.00 |
| Jun 30, 2022 | 151,000.00 |
| Mar 31, 2022 | 103,000.00 |
| Dec 31, 2021 | 50,000.00 |
| Sep 30, 2021 | -12.33 Mn |
| Jun 30, 2021 | 82,000.00 |